Development and validation of sampling and rapid assay methods for vedozilumab and ustekinumab therapeutic drug monitoring

Our goal is to develop and validate simple blood sampling methods and rapid point-of-care assays for therapeutic drug monitoring and biomarker level evaluation for two Crohn's disease biologic drugs vedolizumab and ustekinumab to enable immediate dose adjustment and prediction of response for optimal treatment outcomes